Thus far, only canagliflozin has been found to inhibit ferroptosis in DCM by balancing cardiac iron homeostasis, promoting Xc-/glutathione(GSH)/GPX4 axis (101), and activating the AMPK pathway (102) (Figure 1). The gene discussed is GPX4; the disease is familial dilated cardiomyopathy.